SPP1 and glioblastoma: In addition, according to the Kaplan-Meier and COX survival analyses, we found that high expression of SPP1 in most cancers is indicative of a poor prognosis, such as in CESC, ESCA, GBM, LGG, LIHC, LUAD, MESO, PAAD, PRAD, and STAD.